Article Text

PDF
Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland
  1. J A Salotti1,
  2. V Nanduri2,
  3. M S Pearce1,
  4. L Parker3,
  5. R Lynn4,
  6. K P Windebank1
  1. 1
    Newcastle University, Newcastle upon Tyne, UK
  2. 2
    Watford General Hospital, Watford, UK
  3. 3
    Dalhousie University, Halifax, Canada
  4. 4
    British Paediatric Surveillance Unit, London, UK
  1. Mrs Jane Salotti, Institute of Health and Society - Child Health, Newcastle University, Sir James Spence Institute, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK; jane.salotti{at}ncl.ac.uk

Abstract

Objectives: There are few published studies on the epidemiology of Langerhans cell histiocytosis (LCH). We undertook a survey to ascertain all newly diagnosed cases aged 0–16 years in the UK and Republic of Ireland.

Design: Three methods of ascertainment were used: the British Paediatric Surveillance Unit (BPSU) system, a survey by Newcastle University, and the Children’s Cancer and Leukaemia Group (CCLG) registry. Deaths data were obtained from the UK Office for National Statistics and the Central Statistics Office in Ireland. Clinicians who reported cases were sent a questionnaire to obtain demographic and clinical details.

Results: Over the 2-year period, 94 cases were identified. The age-standardised incidence rate of LCH in children aged 0–14 years was 4.1 per million per year. The sex ratio (M:F) was 1.5:1 and the median age at diagnosis was 5.9 years. Single system disease (predominantly bony involvement) accounted for 73% of cases and 27% had multisystem disease of whom 7% had involvement of “risk organs” (liver, lung, spleen and bone marrow). Three children died, two of whom were diagnosed after death.

Conclusions: This is the first study of LCH to use an active surveillance method with additional sources of ascertainment. Our incidence is comparable with those in other national reports, although it is likely to be an underestimate as each method may have missed some cases, either diagnosed or undiagnosed.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

  • Funding: The study was supported with a grant from the Histiocytosis Research Trust.

  • Ethics approval: The study received appropriate ethics approval by UK and Republic of Ireland ethics bodies.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.